Sanara MedTech, Inc.
(NASDAQ: SMTI)

Sanara MedTech, Inc. engages in the development, marketing, and distribution of biotechnology products to physicians, hospitals, and clinics. It offers CellerateRX Surgical Activated Collagen Adjuvant and HemaQuell Resorbable Bone Hemostat. The company was founded in 1982 and is headquartered in Fort Worth, TX.

22.080

+0.280 (+1.28%)
Range 20.900 - 22.090   (5.69%)
Open 20.900
Previous Close 21.800
Bid Price 35.080
Bid Volume 11
Ask Price 38.760
Ask Volume 10
Volume 2,621
Value -
Remark
Delayed prices. Updated at 05 Dec 2025 23:05.
Data powered by
View All Events

Loading Chart...

Please login to view stock data and analysis